Skip to content
DataLookout
Menu

NCT03260842

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 6 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Apr 30, 2028 to Apr 30, 2030
    • Eligibility criteria expanded, about 4 words
    • Study completion pushed from Apr 30, 2030 to Apr 30, 2032
    • Study description expanded, about 2 words
  2. Minor Study description shortened, about 14 words
    • Collaborators shortened, about 4 words
    v7
  3. Notable Primary completion date: Apr 30, 2023 to Apr 30, 2028
    • Study completion date: Apr 30, 2023 to Apr 30, 2030
    v6
  4. Notable Primary and study completion dates: Apr 30, 2022 to Apr 30, 2023v5
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Pancreas Cancer
Timeframe: 5-10 years

Arms and interventions

Pancreatic Cysts

Patients with pancreatic cyst undergoing endoscopic ultrasound and/or surgery who will have bio-specimens collected

High Risk Individuals

Patients with established family history and/or genetic mutations for Pancreas cancer who will have bio-specimens collected

Diagnostic tests: Bio-Specimen Collection

Sites

1 site in 1 country

  • Stanford UniversityStanford, California, United States